DGDA: Use of antibiotics restricted for coronavirus treatment
28 March 2020
DGDA Director General (DG) Maj Gen Md Mahbubur Rahman said this at a press conference in Dhaka on Monday morning.
At the press conference, Delta Pharma Ltd announced to provide 300,000 necessary medicines (tablets) to treat Covid-19 patients. The medicines include Hydroxychloroquine and Azithromycin.
The director general said 100,000 tablets can be used for 20,000 coronavirus affected patients.
Apart from Delta Pharma, other pharmaceutical companies are also ready to supply medicines, he added
Further reading: Dhaka Tribune
Author(s): Dhaka Tribune
Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!